Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/7/25 20:02 | 2/5/25 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | 7 | M.d | 954 | 41.89 | 0 | 23 | 10 | 261 | D | ||||||||||||||
2/7/25 20:02 | 2/5/25 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | 7 | S.d | -954 | 41.89 | 0 | -23 | 261 | D | |||||||||||||||
2/7/25 20:01 | 2/5/25 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | MA | DO | CEO | 4 | S.d | -2,234 | 41.76 | 0 | -54 | 1,324 | D | |||||||||||||||
12/16/24 06:00 | 12/12/24 | APGE | Health | BioPrd | Biological Products, (No Diag | McKenna Mark C. | MA | D | 1 | P | 991 | 49.54 | 0 | 20 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |